Sustained and focused hepatitis B virus nucleocapsid–specific T‐cell immunity in liver transplant recipients compared to individuals with chronic and self‐limited hepatitis B virus infection

Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft‐ and patient‐survival. Treatment with HBV‐specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT...

Full description

Saved in:
Bibliographic Details
Published inLiver transplantation Vol. 14; no. 4; pp. 478 - 485
Main Authors Bihl, Florian, Loggi, Elisabetta, Chisholm, John V., Biselli, Maurizio, Morelli, Maria C., Cursaro, Carmela, Terrault, Norah A., Bernardi, Mauro, Bertoletti, Antonio, Andreone, Pietro, Brander, Christian
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.04.2008
Subjects
Online AccessGet full text
ISSN1527-6465
1527-6473
1527-6473
DOI10.1002/lt.21384

Cover

Loading…
Abstract Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft‐ and patient‐survival. Treatment with HBV‐specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT outcome. However, the role of HBV‐specific cellular immunity in viral containment in immune suppressed patients in general and in OLT recipients in particular is unclear. To test whether or not OLT recipients maintain robust HBV‐specific cellular immunity, the cellular immune response against HBV was assessed in 15 OLT recipients and 27 individuals with chronic and 24 subjects with self‐limited HBV infection, respectively; using an overlapping peptide set spanning the viral nucleocapsid‐ and envelope‐protein sequences. The data demonstrate that OLT recipients mounted fewer but stronger clusters of differentiation (CD)8 T cell responses than subjects with self‐limited HBV infection and showed a preferential targeting of the nucleocapsid antigen. This focused response pattern was similar to responses seen in chronically infected subjects with undetectable viremia, but significantly different from patients who presented with elevated HBV viremia and who mounted mainly immune responses against the envelope protein. In conclusion, virus‐specific CD4 T cell–mediated responses were only detected in subjects with self‐limited HBV infection. Thus, the profile of the cellular immunity against HBV was in immune suppressed patients similar to subjects with chronic HBV infection with suppressed HBV‐DNA. Liver Transpl 2008. © 2008 AASLD.
AbstractList Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft- and patient-survival. Treatment with HBV-specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT outcome. However, the role of HBV-specific cellular immunity in viral containment in immune suppressed patients in general and in OLT recipients in particular is unclear. To test whether or not OLT recipients maintain robust HBV-specific cellular immunity, the cellular immune response against HBV was assessed in 15 OLT recipients and 27 individuals with chronic and 24 subjects with self-limited HBV infection, respectively; using an overlapping peptide set spanning the viral nucleocapsid- and envelope-protein sequences. The data demonstrate that OLT recipients mounted fewer but stronger clusters of differentiation (CD)8 T cell responses than subjects with self-limited HBV infection and showed a preferential targeting of the nucleocapsid antigen. This focused response pattern was similar to responses seen in chronically infected subjects with undetectable viremia, but significantly different from patients who presented with elevated HBV viremia and who mounted mainly immune responses against the envelope protein. In conclusion, virus-specific CD4 T cell-mediated responses were only detected in subjects with self-limited HBV infection. Thus, the profile of the cellular immunity against HBV was in immune suppressed patients similar to subjects with chronic HBV infection with suppressed HBV-DNA.Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft- and patient-survival. Treatment with HBV-specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT outcome. However, the role of HBV-specific cellular immunity in viral containment in immune suppressed patients in general and in OLT recipients in particular is unclear. To test whether or not OLT recipients maintain robust HBV-specific cellular immunity, the cellular immune response against HBV was assessed in 15 OLT recipients and 27 individuals with chronic and 24 subjects with self-limited HBV infection, respectively; using an overlapping peptide set spanning the viral nucleocapsid- and envelope-protein sequences. The data demonstrate that OLT recipients mounted fewer but stronger clusters of differentiation (CD)8 T cell responses than subjects with self-limited HBV infection and showed a preferential targeting of the nucleocapsid antigen. This focused response pattern was similar to responses seen in chronically infected subjects with undetectable viremia, but significantly different from patients who presented with elevated HBV viremia and who mounted mainly immune responses against the envelope protein. In conclusion, virus-specific CD4 T cell-mediated responses were only detected in subjects with self-limited HBV infection. Thus, the profile of the cellular immunity against HBV was in immune suppressed patients similar to subjects with chronic HBV infection with suppressed HBV-DNA.
Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft- and patient-survival. Treatment with HBV-specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT outcome. However, the role of HBV-specific cellular immunity in viral containment in immune suppressed patients in general and in OLT recipients in particular is unclear. To test whether or not OLT recipients maintain robust HBV-specific cellular immunity, the cellular immune response against HBV was assessed in 15 OLT recipients and 27 individuals with chronic and 24 subjects with self-limited HBV infection, respectively; using an overlapping peptide set spanning the viral nucleocapsid- and envelope-protein sequences. The data demonstrate that OLT recipients mounted fewer but stronger clusters of differentiation (CD)8 T cell responses than subjects with self-limited HBV infection and showed a preferential targeting of the nucleocapsid antigen. This focused response pattern was similar to responses seen in chronically infected subjects with undetectable viremia, but significantly different from patients who presented with elevated HBV viremia and who mounted mainly immune responses against the envelope protein. In conclusion, virus-specific CD4 T cell-mediated responses were only detected in subjects with self-limited HBV infection. Thus, the profile of the cellular immunity against HBV was in immune suppressed patients similar to subjects with chronic HBV infection with suppressed HBV-DNA.
Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft‐ and patient‐survival. Treatment with HBV‐specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT outcome. However, the role of HBV‐specific cellular immunity in viral containment in immune suppressed patients in general and in OLT recipients in particular is unclear. To test whether or not OLT recipients maintain robust HBV‐specific cellular immunity, the cellular immune response against HBV was assessed in 15 OLT recipients and 27 individuals with chronic and 24 subjects with self‐limited HBV infection, respectively; using an overlapping peptide set spanning the viral nucleocapsid‐ and envelope‐protein sequences. The data demonstrate that OLT recipients mounted fewer but stronger clusters of differentiation (CD)8 T cell responses than subjects with self‐limited HBV infection and showed a preferential targeting of the nucleocapsid antigen. This focused response pattern was similar to responses seen in chronically infected subjects with undetectable viremia, but significantly different from patients who presented with elevated HBV viremia and who mounted mainly immune responses against the envelope protein. In conclusion, virus‐specific CD4 T cell–mediated responses were only detected in subjects with self‐limited HBV infection. Thus, the profile of the cellular immunity against HBV was in immune suppressed patients similar to subjects with chronic HBV infection with suppressed HBV‐DNA. Liver Transpl 2008. © 2008 AASLD.
Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft- and patient-survival. Treatment with HBV-specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT outcome. However, the role of HBV-specific cellular immunity in viral containment in immune suppressed patients in general and in OLT recipients in particular is unclear. To test whether or not OLT recipients maintain robust HBV-specific cellular immunity, the cellular immune response against HBV was assessed in 15 OLT recipients and 27 individuals with chronic and 24 subjects with self-limited HBV infection, respectively; using an overlapping peptide set spanning the viral nucleocapsid- and envelope-protein sequences. The data demonstrate that OLT recipients mounted fewer but stronger clusters of differentiation (CD)8 T cell responses than subjects with self-limited HBV infection and showed a preferential targeting of the nucleocapsid antigen. This focused response pattern was similar to responses seen in chronically infected subjects with undetectable viremia, but significantly different from patients who presented with elevated HBV viremia and who mounted mainly immune responses against the envelope protein. In conclusion, virus-specific CD4 T cell-mediated responses were only detected in subjects with self-limited HBV infection. Thus, the profile of the cellular immunity against HBV was in immune suppressed patients similar to subjects with chronic HBV infection with suppressed HBV-DNA. Liver Transpl 2008.
Author Terrault, Norah A.
Loggi, Elisabetta
Biselli, Maurizio
Bertoletti, Antonio
Andreone, Pietro
Chisholm, John V.
Bihl, Florian
Brander, Christian
Morelli, Maria C.
Cursaro, Carmela
Bernardi, Mauro
Author_xml – sequence: 1
  givenname: Florian
  surname: Bihl
  fullname: Bihl, Florian
– sequence: 2
  givenname: Elisabetta
  surname: Loggi
  fullname: Loggi, Elisabetta
– sequence: 3
  givenname: John V.
  surname: Chisholm
  fullname: Chisholm, John V.
– sequence: 4
  givenname: Maurizio
  surname: Biselli
  fullname: Biselli, Maurizio
– sequence: 5
  givenname: Maria C.
  surname: Morelli
  fullname: Morelli, Maria C.
– sequence: 6
  givenname: Carmela
  surname: Cursaro
  fullname: Cursaro, Carmela
– sequence: 7
  givenname: Norah A.
  surname: Terrault
  fullname: Terrault, Norah A.
– sequence: 8
  givenname: Mauro
  surname: Bernardi
  fullname: Bernardi, Mauro
– sequence: 9
  givenname: Antonio
  surname: Bertoletti
  fullname: Bertoletti, Antonio
– sequence: 10
  givenname: Pietro
  surname: Andreone
  fullname: Andreone, Pietro
  email: andreone@med.unibo.it
– sequence: 11
  givenname: Christian
  surname: Brander
  fullname: Brander, Christian
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18324666$$D View this record in MEDLINE/PubMed
BookMark eNp9kUFu1DAUhi3UirYDEidAXkE3GRzbcZIlVBQqjcSCYR05tqN5yLGD7Uw1ux4BiStxkp4ED9MWCRW88bP0vc_P_s_QkfPOIPSiJMuSEPrGpiUtWcOfoNOyonUheM2OHmpRnaCzGL8SUpZVS56ik7JhlAshTtHPz3NMEpzRWDqNB6_mmOuNmWSCBBG_w1sIc8RuVtZ4JacI-vbmR5yMggEUXt_efFfGWgzjODtIOwwOW9iagFOQLk5WuoRDpicwLkWs_DjJkO9IPqMatqBnaSO-hrTBahO8y9b9LNHYIcstjJAeHQncYFQC756h4yErzPO7fYG-XL5fX3wsVp8-XF28XRWKNRUvGqEpZS3Vg-xrXRNGq6qmWkkqy4aLnvWC5UNNNK8U7wWlvJK54m1NOKGGLdDrg3cK_ttsYupGiPvHS2f8HLuWUMZaltcCvfovmYWCs6rJ4Ms7cO5Ho7spwCjDrrtPKAPnB0AFH2Mwwx-EdPvwO5u63-FndPkXqiDJ_QflJMA-1lAcGq7Bmt0_xd1qfeB_AUrIxeg
CitedBy_id crossref_primary_10_1002_lt_21674
crossref_primary_10_1016_j_jhep_2008_08_026
crossref_primary_10_1002_lt_21729
crossref_primary_10_1007_s15010_012_0320_z
crossref_primary_10_1097_QAD_0b013e328359b7ae
crossref_primary_10_1111_jvh_12255
Cites_doi 10.1084/jem.176.1.157
10.1016/S0168-8278(01)00080-0
10.1182/blood.V77.1.195.195
10.1128/JVI.02509-06
10.1002/eji.200737365
10.1038/nm1520
10.1097/00002030-200404090-00004
10.1038/nm1096-1104
10.1128/JVI.02844-06
10.1172/JCI3731
10.1084/jem.181.6.1957
10.1128/JVI.78.11.5707-5719.2004
10.1053/jhep.2001.23045
10.1016/S0022-1759(02)00541-0
10.1084/jem.178.4.1459
10.1172/JCI116950
10.1097/QAD.0b013e328182df03
10.1086/432103
10.1172/JCI118592
10.1111/j.1399-0012.2006.00490.x
10.1186/1479-5876-3-20
10.1099/vir.0.81920-0
10.1038/281646a0
10.4049/jimmunol.173.9.5355
10.1084/jem.181.3.1047
10.7326/0003-4819-96-4-447
10.1016/j.transproceed.2005.10.017
10.1172/JCI118902
10.1089/088922204322996554
10.1038/nature05115
10.1002/lt.20258
10.1053/jhep.2003.50310
10.1099/0022-1317-83-6-1267
10.1002/lt.20492
10.1016/S0168-8278(03)00292-7
10.1097/00007890-200002270-00017
10.1084/jem.191.8.1269
10.1086/491741
10.1128/JVI.78.9.4463-4477.2004
10.1084/jem.20051775
10.4049/jimmunol.145.10.3442
ContentType Journal Article
Copyright Copyright © 2008 American Association for the Study of Liver Diseases
(c) 2008 AASLD.
Copyright_xml – notice: Copyright © 2008 American Association for the Study of Liver Diseases
– notice: (c) 2008 AASLD.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
DOI 10.1002/lt.21384
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-6473
EndPage 485
ExternalDocumentID 18324666
10_1002_lt_21384
LT21384
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Swiss National Science Foundation
  funderid: SNF‐PBSKB‐102686
– fundername: Associazione per la Ricerca sulle Malattie Epatiche (Bologna, Italy)
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1B1
1L6
1OC
1~5
24P
31~
33P
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AAOCO
AAONW
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABMAC
ABPVW
ABWVN
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFO
ACGFS
ACLDA
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
AECAP
AEEZP
AEGXH
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD6
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RIG
ROL
RPZ
RWI
RX1
SEW
SSZ
SUPJJ
TEORI
UB1
UHS
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
X7M
XG1
XV2
ZZTAW
~IA
~WT
AAFWJ
AAYXX
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
ID FETCH-LOGICAL-c3854-86d22392dfab7d70325572dca2a1846b3b63ca270d45c4b62245a5c44970402e3
IEDL.DBID DR2
ISSN 1527-6465
1527-6473
IngestDate Thu Jul 10 18:06:25 EDT 2025
Fri Jul 11 09:59:27 EDT 2025
Mon Jul 21 05:44:17 EDT 2025
Tue Jul 01 05:14:47 EDT 2025
Thu Apr 24 23:06:15 EDT 2025
Wed Jan 22 16:26:33 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License (c) 2008 AASLD.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3854-86d22392dfab7d70325572dca2a1846b3b63ca270d45c4b62245a5c44970402e3
Notes These authors contributed equally to this study.
Telephone: 39.051.6363618; FAX: 39.051.345806
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/lt.21384
PMID 18324666
PQID 70464358
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_902339333
proquest_miscellaneous_70464358
pubmed_primary_18324666
crossref_primary_10_1002_lt_21384
crossref_citationtrail_10_1002_lt_21384
wiley_primary_10_1002_lt_21384_LT21384
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2008
2008-04-00
2008-Apr
20080401
PublicationDateYYYYMMDD 2008-04-01
PublicationDate_xml – month: 04
  year: 2008
  text: April 2008
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: United States
PublicationTitle Liver transplantation
PublicationTitleAlternate Liver Transpl
PublicationYear 2008
Publisher Wiley Subscription Services, Inc., A Wiley Company
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
References 2005; 192
2004; 20
2000; 69
1991; 77
1982; 96
2003; 38
2003; 39
2004
1990; 145
1996; 98
2007; 13
1996; 97
2003; 275
2000; 191
2007; 37
2004; 10
2006; 20
2000; 14
2004; 18
2002; 83
1992; 176
2006; 87
2004; 173
2004; 78
2007; 81
2005; 3
2005; 37
2001; 33
2001; 34
1979; 281
2007; 21
2006; 203
1996; 2
1998; 102
1994; 93
2005; 11
1993; 178
1995; 181
2006; 443
Boni (R16-13-20250326) 2001; 33
KiddLjunggren (R25-13-20250326) 2002; 83
Rehermann (R8-13-20250326) 1996; 97
Murray (R33-13-20250326) 1992; 176
Rehermann (R7-13-20250326) 1995; 181
Kaufmann (R26-13-20250326) 2004; 78
Kiepiela (R36-13-20250326) 2007; 13
Woodberry (R38-13-20250326) 2005; 192
Marzano (R5-13-20250326) 2001; 34
Watts (R40-13-20250326) 1993; 178
Day (R41-13-20250326) 2006; 443
Marinos (R42-13-20250326) 2000; 69
Bertoletti (R10-13-20250326) 2003; 38
Woodberry (R37-13-20250326) 2005; 192
Bertoletti (R35-13-20250326) 2006; 87
Maini (R11-13-20250326) 2000; 191
Murakami (R17-13-20250326) 2006; 20
Reed (R19-13-20250326) 1991; 77
Camci (R2-13-20250326) 2005; 37
Michalak (R34-13-20250326) 1994; 93
Boni (R14-13-20250326) 1998; 102
Hoofnagle (R18-13-20250326) 1982; 96
Norris (R27-13-20250326) 2004; 20
Simitsek (R39-13-20250326) 1995; 181
Frahm (R29-13-20250326) 2007; 37
Draenert (R23-13-20250326) 2003; 275
Webster (R12-13-20250326) 2004; 78
Roche (R4-13-20250326) 2004; 10
Bihl (R20-13-20250326) 2005; 3
Boni (R13-13-20250326) 2007; 81
Draenert (R28-13-20250326) 2004; 18
Rosen (R44-13-20250326) 2004; 173
Rehermann (R6-13-20250326) 1996; 2
Ferrari (R32-13-20250326) 1990; 145
Bihl (R31-13-20250326) 2007; 21
Klein (R43-13-20250326) 2006; 203
Boni (R15-13-20250326) 2003; 39
McGory (R3-13-20250326) 2000; 14
Terrault (R1-13-20250326) 2005; 11
Galibert (R24-13-20250326) 1979; 281
Penna (R9-13-20250326) 1996; 98
Bihl (R30-13-20250326) 2007; 81
References_xml – volume: 178
  start-page: 1459
  year: 1993
  end-page: 1463
  article-title: Suppressive effect of antibody on processing of T cell epitopes
  publication-title: J Exp Med
– volume: 281
  start-page: 646
  year: 1979
  end-page: 650
  article-title: Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
  publication-title: Nature
– volume: 145
  start-page: 3442
  year: 1990
  end-page: 3449
  article-title: Cellular immune response to hepatitis B virus‐encoded antigens in acute and chronic hepatitis B virus infection
  publication-title: J Immunol
– start-page: 1‐63
  end-page: 100
– volume: 33
  start-page: 963
  year: 2001
  end-page: 971
  article-title: Lamivudine treatment can overcome cytotoxic T‐cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy
  publication-title: Hepatology
– volume: 443
  start-page: 350
  year: 2006
  end-page: 354
  article-title: PD‐1 expression on HIV‐specific T cells is associated with T‐cell exhaustion and disease progression
  publication-title: Nature
– start-page: 78
  year: 2004
  article-title: Consistent cytotoxic‐T‐lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities
  publication-title: J Virol
– volume: 98
  start-page: 1185
  year: 1996
  end-page: 1194
  article-title: Long‐lasting memory T cell responses following self‐limited acute hepatitis B
  publication-title: J Clin Invest
– volume: 81
  start-page: 4215
  year: 2007
  end-page: 4225
  article-title: Characterization of HBV‐specific T cell dysfunction in chronic HBV infection
  publication-title: J Virol
– volume: 78
  start-page: 4463
  year: 2004
  end-page: 4477
  article-title: Comprehensive analysis of human immunodeficiency virus type 1‐specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides
  publication-title: J Virol
– volume: 13
  start-page: 46
  year: 2007
  end-page: 53
  article-title: CD8+ T‐cell responses to different HIV proteins have discordant associations with viral load
  publication-title: Nat Med
– volume: 37
  start-page: 4350
  year: 2005
  end-page: 4353
  article-title: Liver transplantation for hepatitis B in the United States
  publication-title: Transplant Proc
– volume: 20
  start-page: 351
  year: 2006
  end-page: 358
  article-title: Reactivation of hepatitis and lamivudine therapy in 11 HBsAg‐positive renal allograft recipients: a single centre experience
  publication-title: Clin Transplant
– volume: 192
  start-page: 622
  year: 2005
  end-page: 629
  article-title: Impact of Kaposi sarcoma‐associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins
  publication-title: J Infect Dis
– volume: 10
  start-page: S74
  year: 2004
  end-page: S85
  article-title: Evolving strategies to prevent HBV recurrence
  publication-title: Liver Transpl
– volume: 14
  start-page: 29
  issue: Suppl 2
  year: 2000
  end-page: 38
  article-title: Pharmacoeconomic analysis of HBV liver transplant therapies
  publication-title: Clin Transplant
– volume: 34
  start-page: 903
  year: 2001
  end-page: 910
  article-title: Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
  publication-title: J Hepatol
– volume: 96
  start-page: 447
  year: 1982
  end-page: 449
  article-title: Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
  publication-title: Ann Intern Med
– volume: 69
  start-page: 559
  year: 2000
  end-page: 568
  article-title: Immunopathogenesis of hepatitis B virus recurrence after liver transplantation
  publication-title: Transplantation
– volume: 39
  start-page: 595
  year: 2003
  end-page: 605
  article-title: Transient restoration of anti‐viral T cell responses induced by lamivudine therapy in chronic hepatitis B
  publication-title: J Hepatol
– volume: 181
  start-page: 1957
  year: 1995
  end-page: 1963
  article-title: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants
  publication-title: J Exp Med
– volume: 181
  start-page: 1047
  year: 1995
  end-page: 1058
  article-title: The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
  publication-title: J Exp Med
– volume: 81
  start-page: 4904
  year: 2007
  end-page: 4908
  article-title: Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma‐associated herpesvirus and Epstein‐Barr virus induce T‐cell responses with similar functional properties and memory phenotypes
  publication-title: J Virol
– volume: 77
  start-page: 195
  year: 1991
  end-page: 200
  article-title: Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen
  publication-title: Blood
– volume: 173
  start-page: 5355
  year: 2004
  end-page: 5359
  article-title: Cutting edge: identification of hepatitis C virus‐specific CD8+ T cells restricted by donor HLA alleles following liver transplantation
  publication-title: J Immunol
– volume: 11
  start-page: 716
  year: 2005
  end-page: 732
  article-title: Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective
  publication-title: Liver Transpl
– volume: 2
  start-page: 1104
  year: 1996
  end-page: 1108
  article-title: The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T‐lymphocyte response
  publication-title: Nat Med
– volume: 93
  start-page: 230
  year: 1994
  end-page: 239
  article-title: Hepatitis B virus persistence after recovery from acute viral hepatitis
  publication-title: J Clin Invest
– volume: 37
  start-page: 2419
  year: 2007
  end-page: 2433
  article-title: Extensive HLA class I allele promiscuity among viral CTL epitopes
  publication-title: Eur J Immunol
– volume: 191
  start-page: 1269
  year: 2000
  end-page: 1280
  article-title: The role of virus‐specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
  publication-title: J Exp Med
– volume: 78
  start-page: 5707
  year: 2004
  end-page: 5719
  article-title: Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy
  publication-title: J Virol
– volume: 203
  start-page: 437
  year: 2006
  end-page: 447
  article-title: Complete differentiation of CD8+ T cells activated locally within the transplanted liver
  publication-title: J Exp Med
– volume: 18
  start-page: 871
  year: 2004
  end-page: 876
  article-title: Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels
  publication-title: AIDS
– volume: 21
  start-page: 1245
  year: 2007
  end-page: 1252
  article-title: Kaposi's sarcoma‐associated herpesvirus‐specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C‐infected individuals with Kaposi's sarcoma
  publication-title: AIDS
– volume: 3
  start-page: 20
  year: 2005
  article-title: Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti‐CD3 mAb T‐cell expansion and “RecycleSpot”
  publication-title: J Transl Med
– volume: 38
  start-page: 4
  year: 2003
  end-page: 13
  article-title: Kinetics of the immune response during HBV and HCV infection
  publication-title: Hepatology
– volume: 176
  start-page: 157
  year: 1992
  end-page: 168
  article-title: Identification of target antigens for the human cytotoxic T cell response to Epstein‐Barr virus (EBV): implications for the immune control of EBV‐positive malignancies
  publication-title: J Exp Med
– volume: 97
  start-page: 1655
  year: 1996
  end-page: 1665
  article-title: Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
  publication-title: J Clin Invest
– volume: 102
  start-page: 968
  year: 1998
  end-page: 975
  article-title: Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
  publication-title: J Clin Invest
– volume: 192
  start-page: 1513
  year: 2005
  end-page: 1524
  article-title: Differential targeting and shifts in the immunodominance of Epstein‐Barr virus–specific CD8 and CD4 T cell responses during acute and persistent infection
  publication-title: J Infect Dis
– volume: 20
  start-page: 315
  year: 2004
  end-page: 325
  article-title: Fine specificity and cross‐clade reactivity of HIV type 1 Gag‐specific CD4+ T cells
  publication-title: AIDS Res Hum Retroviruses
– volume: 275
  start-page: 19
  year: 2003
  end-page: 29
  article-title: Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses
  publication-title: J Immunol Methods
– volume: 83
  start-page: 1267
  year: 2002
  end-page: 1280
  article-title: Genetic variability in hepatitis B viruses
  publication-title: J Gen Virol
– volume: 87
  start-page: 1439
  year: 2006
  end-page: 1449
  article-title: The immune response during hepatitis B virus infection
  publication-title: J Gen Virol
– volume: 176
  start-page: 157
  year: 1992
  ident: R33-13-20250326
  article-title: Identification of target antigens for the human cytotoxic T cell response to EpsteinBarr virus (EBV): implications for the immune control of EBVpositive malignancies.
  publication-title: J Exp Med
  doi: 10.1084/jem.176.1.157
– volume: 34
  start-page: 903
  year: 2001
  ident: R5-13-20250326
  article-title: Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(01)00080-0
– volume: 77
  start-page: 195
  year: 1991
  ident: R19-13-20250326
  article-title: Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen.
  publication-title: Blood
  doi: 10.1182/blood.V77.1.195.195
– volume: 81
  start-page: 4904
  year: 2007
  ident: R30-13-20250326
  article-title: 3rd, Henry LM, Suscovich TJ, Brown EE, et al. Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcomaassociated herpesvirus and EpsteinBarr virus induce Tcell responses with similar functional properties and memory phenotypes.
  publication-title: J Virol
  doi: 10.1128/JVI.02509-06
– volume: 37
  start-page: 2419
  year: 2007
  ident: R29-13-20250326
  article-title: Extensive HLA class I allele promiscuity among viral CTL epitopes.
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200737365
– volume: 13
  start-page: 46
  year: 2007
  ident: R36-13-20250326
  article-title: CD8 Tcell responses to different HIV proteins have discordant associations with viral load.
  publication-title: Nat Med
  doi: 10.1038/nm1520
– volume: 18
  start-page: 871
  year: 2004
  ident: R28-13-20250326
  article-title: Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels.
  publication-title: AIDS
  doi: 10.1097/00002030-200404090-00004
– volume: 2
  start-page: 1104
  year: 1996
  ident: R6-13-20250326
  article-title: The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic Tlymphocyte response.
  publication-title: Nat Med
  doi: 10.1038/nm1096-1104
– volume: 81
  start-page: 4215
  year: 2007
  ident: R13-13-20250326
  article-title: Characterization of HBVspecific T cell dysfunction in chronic HBV infection.
  publication-title: J Virol
  doi: 10.1128/JVI.02844-06
– volume: 102
  start-page: 968
  year: 1998
  ident: R14-13-20250326
  article-title: Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
  publication-title: J Clin Invest
  doi: 10.1172/JCI3731
– volume: 181
  start-page: 1957
  year: 1995
  ident: R39-13-20250326
  article-title: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants.
  publication-title: J Exp Med
  doi: 10.1084/jem.181.6.1957
– volume: 78
  start-page: 5707
  year: 2004
  ident: R12-13-20250326
  article-title: Longitudinal analysis of CD8 T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.
  publication-title: J Virol
  doi: 10.1128/JVI.78.11.5707-5719.2004
– volume: 33
  start-page: 963
  year: 2001
  ident: R16-13-20250326
  article-title: Lamivudine treatment can overcome cytotoxic Tcell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.
  publication-title: Hepatology
  doi: 10.1053/jhep.2001.23045
– volume: 275
  start-page: 19
  year: 2003
  ident: R23-13-20250326
  article-title: Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
  publication-title: J Immunol Methods
  doi: 10.1016/S0022-1759(02)00541-0
– volume: 178
  start-page: 1459
  year: 1993
  ident: R40-13-20250326
  article-title: Suppressive effect of antibody on processing of T cell epitopes.
  publication-title: J Exp Med
  doi: 10.1084/jem.178.4.1459
– volume: 93
  start-page: 230
  year: 1994
  ident: R34-13-20250326
  article-title: Hepatitis B virus persistence after recovery from acute viral hepatitis.
  publication-title: J Clin Invest
  doi: 10.1172/JCI116950
– volume: 21
  start-page: 1245
  year: 2007
  ident: R31-13-20250326
  article-title: 3rd, Dollard S, Gumbi P, et al. Kaposi's sarcomaassociated herpesvirusspecific immune reconstitution and antiviral effect of combined HAARTchemotherapy in HIV clade Cinfected individuals with Kaposi's sarcoma.
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328182df03
– volume: 192
  start-page: 622
  year: 2005
  ident: R38-13-20250326
  article-title: Impact of Kaposi sarcomaassociated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins.
  publication-title: J Infect Dis
  doi: 10.1086/432103
– volume: 97
  start-page: 1655
  year: 1996
  ident: R8-13-20250326
  article-title: Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
  publication-title: J Clin Invest
  doi: 10.1172/JCI118592
– volume: 20
  start-page: 351
  year: 2006
  ident: R17-13-20250326
  article-title: Reactivation of hepatitis and lamivudine therapy in 11 HBsAgpositive renal allograft recipients: a single centre experience.
  publication-title: Clin Transplant
  doi: 10.1111/j.1399-0012.2006.00490.x
– volume: 3
  start-page: 20
  year: 2005
  ident: R20-13-20250326
  article-title: 3rd, Hewitt HS, Henry LM, Linde C, et al. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, antiCD3 mAb Tcell expansion and RecycleSpot.
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-3-20
– volume: 87
  start-page: 1439
  year: 2006
  ident: R35-13-20250326
  article-title: The immune response during hepatitis B virus infection.
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.81920-0
– volume: 281
  start-page: 646
  year: 1979
  ident: R24-13-20250326
  article-title: Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.
  publication-title: Nature
  doi: 10.1038/281646a0
– volume: 173
  start-page: 5355
  year: 2004
  ident: R44-13-20250326
  article-title: Cutting edge: identification of hepatitis C virusspecific CD8 T cells restricted by donor HLA alleles following liver transplantation.
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.9.5355
– volume: 181
  start-page: 1047
  year: 1995
  ident: R7-13-20250326
  article-title: The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
  publication-title: J Exp Med
  doi: 10.1084/jem.181.3.1047
– volume: 96
  start-page: 447
  year: 1982
  ident: R18-13-20250326
  article-title: Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-96-4-447
– volume: 14
  start-page: 29
  issue: Suppl 2
  year: 2000
  ident: R3-13-20250326
  article-title: Pharmacoeconomic analysis of HBV liver transplant therapies.
  publication-title: Clin Transplant
– volume: 37
  start-page: 4350
  year: 2005
  ident: R2-13-20250326
  article-title: Liver transplantation for hepatitis B in the United States.
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2005.10.017
– volume: 98
  start-page: 1185
  year: 1996
  ident: R9-13-20250326
  article-title: Longlasting memory T cell responses following selflimited acute hepatitis B.
  publication-title: J Clin Invest
  doi: 10.1172/JCI118902
– volume: 20
  start-page: 315
  year: 2004
  ident: R27-13-20250326
  article-title: Fine specificity and crossclade reactivity of HIV type 1 Gagspecific CD4 T cells.
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/088922204322996554
– volume: 443
  start-page: 350
  year: 2006
  ident: R41-13-20250326
  article-title: PD1 expression on HIVspecific T cells is associated with Tcell exhaustion and disease progression.
  publication-title: Nature
  doi: 10.1038/nature05115
– volume: 10
  start-page: S74
  year: 2004
  ident: R4-13-20250326
  article-title: Evolving strategies to prevent HBV recurrence.
  publication-title: Liver Transpl
  doi: 10.1002/lt.20258
– volume: 38
  start-page: 4
  year: 2003
  ident: R10-13-20250326
  article-title: Kinetics of the immune response during HBV and HCV infection.
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50310
– volume: 83
  start-page: 1267
  year: 2002
  ident: R25-13-20250326
  article-title: Genetic variability in hepatitis B viruses.
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-83-6-1267
– volume: 11
  start-page: 716
  year: 2005
  ident: R1-13-20250326
  article-title: Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective.
  publication-title: Liver Transpl
  doi: 10.1002/lt.20492
– volume: 39
  start-page: 595
  year: 2003
  ident: R15-13-20250326
  article-title: Transient restoration of antiviral T cell responses induced by lamivudine therapy in chronic hepatitis B.
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(03)00292-7
– volume: 69
  start-page: 559
  year: 2000
  ident: R42-13-20250326
  article-title: Immunopathogenesis of hepatitis B virus recurrence after liver transplantation.
  publication-title: Transplantation
  doi: 10.1097/00007890-200002270-00017
– volume: 191
  start-page: 1269
  year: 2000
  ident: R11-13-20250326
  article-title: The role of virusspecific CD8() cells in liver damage and viral control during persistent hepatitis B virus infection.
  publication-title: J Exp Med
  doi: 10.1084/jem.191.8.1269
– volume: 192
  start-page: 1513
  year: 2005
  ident: R37-13-20250326
  article-title: Differential targeting and shifts in the immunodominance of EpsteinBarr virus-specific CD8 and CD4 T cell responses during acute and persistent infection.
  publication-title: J Infect Dis
  doi: 10.1086/491741
– volume: 78
  start-page: 4463
  year: 2004
  ident: R26-13-20250326
  article-title: Comprehensive analysis of human immunodeficiency virus type 1specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.
  publication-title: J Virol
  doi: 10.1128/JVI.78.9.4463-4477.2004
– volume: 203
  start-page: 437
  year: 2006
  ident: R43-13-20250326
  article-title: Complete differentiation of CD8 T cells activated locally within the transplanted liver.
  publication-title: J Exp Med
  doi: 10.1084/jem.20051775
– volume: 145
  start-page: 3442
  year: 1990
  ident: R32-13-20250326
  article-title: Cellular immune response to hepatitis B virusencoded antigens in acute and chronic hepatitis B virus infection.
  publication-title: J Immunol
  doi: 10.4049/jimmunol.145.10.3442
SSID ssj0011590
Score 1.8946366
Snippet Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft‐ and patient‐survival. Treatment with...
Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft- and patient-survival. Treatment with...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 478
SubjectTerms Antibody Specificity
CD4 antigen
Chronic infection
Cyclosporine - therapeutic use
Data processing
Differentiation
DNA, Viral - analysis
Envelope protein
Hepatitis B - immunology
Hepatitis B e Antigens - blood
Hepatitis B Surface Antigens - blood
Hepatitis B virus
Hepatitis B virus - genetics
Hepatitis B virus - immunology
Hepatitis B, Chronic - immunology
Humans
Immunity
Immunity (cell-mediated)
Immunoglobulins
Immunosuppressive Agents - therapeutic use
Liver transplantation
Liver Transplantation - immunology
Lymphocytes - immunology
Lymphocytes T
Nucleocapsid - immunology
Nucleocapsids
Recurrence
T-Lymphocytes - immunology
Tacrolimus - therapeutic use
Viral Load
Viremia
Title Sustained and focused hepatitis B virus nucleocapsid–specific T‐cell immunity in liver transplant recipients compared to individuals with chronic and self‐limited hepatitis B virus infection
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Flt.21384
https://www.ncbi.nlm.nih.gov/pubmed/18324666
https://www.proquest.com/docview/70464358
https://www.proquest.com/docview/902339333
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LatwwFBUli9JN3w_3eQulXXkyY8myvewrhNJ00U4g0IWxHiamxjPEcqFd5RMK_aV-Sb6k90r2hLQJlK4sg2zJ1tXVkXTuEWPPEPSq2oo0VlapWGRzHReirmKRLgw6P20yH-W690Hu7ot3B-nByKqkWJigD7FZcKOe4f01dfBK9dunoqGtmyULnpMU6IJLks1_83GjHIU4xy-v0KGtsRQynXRn58n29ODZkegveHkWrfrhZuca-zxVNLBMvswGp2b6-x8ajv_3JdfZ1RGFwstgNjfYJdvdZJf3xn32W-zXpxBXZQ1UnYF6pYce04eW-Neu6eEVfG2Ohh46kkPG4XCNRn1y_JPiNol7BMuT4x-0JwCNjz9x36DpoCUOCDgvp95iiwIpa6wpILOHiQsPbgXNJkisB1onBh0UfH1detvW-PI2BGadU6WJXtbdZvs7b5evd-PxvIdY8zwVcS4NgpUiMXWlMoOuCKc7WWJ0lVQ4D5WKK8nxJpsbkWqhJKKPtMKUKDJ0RYnld9hWt-rsPQbWzGtZa6V1roSovUaOIKPEwTgptInYi6ntSz2KodOZHG0ZZJyTsnWlb5SIPd3kXAcBkHPyPJnMp8TeSb-36uxq6MuMdo55mkcMLshRIGjiBec8YneD4Z0Wg95W4PQyYs-9-VxYfvl-6a_3_zXjA3Yl8F6IgfSQbbmjwT5CcOXUY9-NfgPwaSfX
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgGXlldpKFAjIThlu42dlzjxqhbY7QG2Ug9IUfyIiIiyqyapVE79CUj8JX5Jfwkz9marQishTnGkSezE4_E39sxngGcIemVhROhLI6Uv4qHyU1Hkvgh3NRo_pWOb5TrZj0YH4sNheLgCL_tcGMcPsVxwo5Fh7TUNcFqQ3jlnDa3aQbDLE3ENrgvEGeR5vf205I5CpGMXWOjYVj9CgZ55dhjs9E9enIv-ApgX8aqdcPbW4UvfVBdn8m3QtXKgvv_B4vif33Ib1hZAlL1ymnMHVkx9F25MFlvt9-DXZ5daZTTLa82KmeoaLH81FILdlg17zY7Lo65hNTEi44w4R70-O_1JqZsUfsSmZ6c_aFuAlTYFpT1hZc0qCgNhrWVUr7BTGZFrzCkns2F9ODxrZ6xc5ok1jJaKmXIkvrYtjakKfHnlcrMuaVIfYVbfh4O9d9M3I39x5IOveBIKP4k04pU00EUuY43WCD2eONAqD3J0RSPJZcTxJh5qESohIwQgYY4lkcZojQLDN2C1ntVmE5jRwyIqlFQqkUIUliZHkF7ifBykSnvwou_8TC340OlYjipzTM5BVrWZ7RQPni4l544D5BKZ7V5_Mhyg9Hvz2sy6Jotp85iHiQfsCokUcRNPOecePHCad14NGlyBHqYHz63-XFl_Np7a68N_FdyGm6PpZJyN3-9_3IJbLgyGApIewWp71JnHiLVa-cSOqd9DIyv2
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFLWgSBUv7EvYepEQPGU6jZ3tkW1UoK0QTKVKPETxJiKizKhJkOCpn4DEL_El_RLutZOpCq2EeIojObETX18f2-ceM_YEQa-0RsShNFKGIp2qMBe2DEW8pdH5KZ26KNfdvWR7X7w9iA8GViXFwnh9iNWCG_UM56-pgy-13TwRDa27SbTFM3GRXRIJAgkCRB9W0lEIdNz6Cp3aGiYiiUfh2Wm0OT55eij6C1-ehqtuvJldZZ_GmnqayZdJ38mJ-v6HiOP_fco1dmWAofDc2811dsE0N9j67rDRfpP9-ugDq4yGstFgF6pvMf3ZEAG7q1p4AV-rw76FhvSQcTxcolUfH_2kwE0iH8H8-OgHbQpA5QJQum9QNVATCQQ6p6deY5MCSWssKSKzhZEMD90CqlWUWAu0UAzKS_i6urSmtvjy2kdmnVGlkV_W3GL7s9fzl9vhcOBDqHgWizBLNKKVPNK2lKlGX4TznTTSqoxKnIgmksuE40061SJWQiYIP-ISUyJP0RdFht9ma82iMXcZGD21iVVSqUwKYZ1IjiCrxNE4ypUO2LOx7Qs1qKHToRx14XWco6LuCtcoAXu8yrn0CiBn5NkYzafA7km_t2zMom-LlLaOeZwFDM7JkSNq4jnnPGB3vOGdFIPuVuD8MmBPnfmcW36xM3fXe_-acYOtv381K3be7L27zy57DgyxkR6wte6wNw8RaHXyketRvwG1Jyql
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sustained+and+focused+hepatitis+B+virus+nucleocapsid-specific+T-cell+immunity+in+liver+transplant+recipients+compared+to+individuals+with+chronic+and+self-limited+hepatitis+B+virus+infection&rft.jtitle=Liver+transplantation&rft.au=Bihl%2C+Florian&rft.au=Loggi%2C+Elisabetta&rft.au=Chisholm%2C+3rd%2C+John+V&rft.au=Biselli%2C+Maurizio&rft.date=2008-04-01&rft.eissn=1527-6473&rft.volume=14&rft.issue=4&rft.spage=478&rft_id=info:doi/10.1002%2Flt.21384&rft_id=info%3Apmid%2F18324666&rft.externalDocID=18324666
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-6465&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-6465&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-6465&client=summon